Skip to main content
placeholder image

Induced pluripotent stem cells for 2D and 3D modelling the biological basis of schizophrenia and screening possible therapeutics

Journal Article


Abstract


  • Induced pluripotent stem cells (iPSCs) are providing unprecedented insight into complex neuropsychiatric disorders such as schizophrenia (SZ). Here we review the use of iPSCs for investigating the etiopathology and treatment of SZ, beginning with conventional in vitro two-dimensional (2D; monolayer) cell modelling, through to more advanced 3D tissue studies. With the advent of 3D modelling, utilising advanced differentiation paradigms and additive manufacturing technologies, inclusive of patient-specific cerebral/neural organoids and bioprinted neural tissues, such live disease-relevant tissue systems better recapitulate “within-body” tissue function and pathobiology. We posit that by enabling better understanding of biological causality, these evolving strategies will yield novel therapeutic targets and accordingly, drug candidates.

Publication Date


  • 2021

Citation


  • Tomaskovic-Crook, E., Guerrieri-Cortesi, K., & Crook, J. M. (2021). Induced pluripotent stem cells for 2D and 3D modelling the biological basis of schizophrenia and screening possible therapeutics. Brain Research Bulletin, 175, 48-62. doi:10.1016/j.brainresbull.2021.07.004

Scopus Eid


  • 2-s2.0-85110664882

Start Page


  • 48

End Page


  • 62

Volume


  • 175

Abstract


  • Induced pluripotent stem cells (iPSCs) are providing unprecedented insight into complex neuropsychiatric disorders such as schizophrenia (SZ). Here we review the use of iPSCs for investigating the etiopathology and treatment of SZ, beginning with conventional in vitro two-dimensional (2D; monolayer) cell modelling, through to more advanced 3D tissue studies. With the advent of 3D modelling, utilising advanced differentiation paradigms and additive manufacturing technologies, inclusive of patient-specific cerebral/neural organoids and bioprinted neural tissues, such live disease-relevant tissue systems better recapitulate “within-body” tissue function and pathobiology. We posit that by enabling better understanding of biological causality, these evolving strategies will yield novel therapeutic targets and accordingly, drug candidates.

Publication Date


  • 2021

Citation


  • Tomaskovic-Crook, E., Guerrieri-Cortesi, K., & Crook, J. M. (2021). Induced pluripotent stem cells for 2D and 3D modelling the biological basis of schizophrenia and screening possible therapeutics. Brain Research Bulletin, 175, 48-62. doi:10.1016/j.brainresbull.2021.07.004

Scopus Eid


  • 2-s2.0-85110664882

Start Page


  • 48

End Page


  • 62

Volume


  • 175